Does RITUXIMAB Cause Injection site extravasation? 215 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 215 reports of Injection site extravasation have been filed in association with RITUXIMAB (Rituxan). This represents 0.1% of all adverse event reports for RITUXIMAB.
215
Reports of Injection site extravasation with RITUXIMAB
0.1%
of all RITUXIMAB reports
0
Deaths
102
Hospitalizations
How Dangerous Is Injection site extravasation From RITUXIMAB?
Of the 215 reports, 102 (47.4%) required hospitalization, and 7 (3.3%) were considered life-threatening.
Is Injection site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RITUXIMAB. However, 215 reports have been filed with the FAERS database.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Injection site extravasation?
EXENATIDE (2,320)
ETANERCEPT (1,139)
ADALIMUMAB (381)
SEMAGLUTIDE (342)
VEDOLIZUMAB (237)
SOMATROPIN (230)
REGADENOSON (226)
EVOLOCUMAB (188)
DUPILUMAB (170)
FREMANEZUMAB-VFRM (166)
Which RITUXIMAB Alternatives Have Lower Injection site extravasation Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE